EUVIMEDEUVIMED entdecken
Crossref

Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma

James E. Carlton, Iuliia Kovalenko

Annals of Internal Medicine: Clinical Cases · 01.08.2026 · 5 (8)

DOI: 10.7326/aimcc.2026.0148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.08.2026. Verfasst von James E. Carlton und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Carlton, J. E., & Kovalenko, I. (2026). Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma. Annals of Internal Medicine: Clinical Cases, 5(8). https://doi.org/10.7326/aimcc.2026.0148

Vancouver

Carlton JE, Kovalenko I. Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma. Annals of Internal Medicine: Clinical Cases. 2026;5(8). doi:10.7326/aimcc.2026.0148

BibTeX
@article{Carlton2026,
  author = {Carlton, James E. and Kovalenko, Iuliia},
  title = {Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma},
  journal = {Annals of Internal Medicine: Clinical Cases},
  year = {2026},
  volume = {5},
  number = {8},
  doi = {10.7326/aimcc.2026.0148}
}
Kostenlos starten →